Kyverna Therapeutics, Inc. (KYTX) Earnings
NASDAQ·Healthcare·Biotechnology
$5.62
+6.67%
Mkt Cap $361.17M
EPS — Estimate vs Actual
Mkt Cap
$361.17M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$3.28
NASDAQ·Healthcare·Biotechnology
$5.62
+6.67%
Mkt Cap $361.17M
Mkt Cap
$361.17M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$3.28